111 related articles for article (PubMed ID: 24623860)
1. Co-occurrence of second primary malignancy in patients with thyroid cancer.
Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
[TBL] [Abstract][Full Text] [Related]
2. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
3. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
4. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
5. Pattern of second primary malignancies in thyroid cancer patients.
Okere PC; Olusina DB; Shamim SA; Shandra V; Tushar M; Sellam K; Bal C
Niger J Clin Pract; 2013; 16(1):96-9. PubMed ID: 23377480
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.
Lee YT; Liu CJ; Hu YW; Teng CJ; Tzeng CH; Yeh CM; Chen TJ; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC; Chen MH; Teng HW; Liu JH; Yen CC
Medicine (Baltimore); 2015 Jul; 94(26):e1079. PubMed ID: 26131831
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
[TBL] [Abstract][Full Text] [Related]
9. Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC
Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917
[TBL] [Abstract][Full Text] [Related]
10. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
11. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
[TBL] [Abstract][Full Text] [Related]
12. Head and neck mucoepidermoid carcinoma: a curious association with second primary malignancy.
Chan RC; Chan JY
Otolaryngol Head Neck Surg; 2014 Nov; 151(5):797-801. PubMed ID: 25245134
[TBL] [Abstract][Full Text] [Related]
13. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
14. Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.
Hung YP; Liu CJ; Hu YW; Chen MH; Li CP; Yeh CM; Chiou TJ; Chen TJ; Yang MH; Chao Y
Medicine (Baltimore); 2015 Sep; 94(38):e1626. PubMed ID: 26402833
[TBL] [Abstract][Full Text] [Related]
15. Comparison of secondary and primary thyroid cancer in adolescents and young adults.
Goldfarb M; Freyer DR
Cancer; 2014 Apr; 120(8):1155-61. PubMed ID: 24615715
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers.
Al-Qahtani KH; Al-Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Al-Hussain H; Maklad AM
Saudi Med J; 2015 Apr; 36(4):442-8. PubMed ID: 25828281
[TBL] [Abstract][Full Text] [Related]
18. Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.
Brownlie B; Mercer P; Turner J; Allison R
N Z Med J; 2008 Aug; 121(1279):36-45. PubMed ID: 18709046
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancies in women with papillary thyroid cancer.
Canchola AJ; Horn-Ross PL; Purdie DM
Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
[TBL] [Abstract][Full Text] [Related]
20. [Cancer statistics of Şırnak city].
Bozkurt K; Bektaş SS; Doğru N
Turk Patoloji Derg; 2011; 27(3):230-4. PubMed ID: 21935873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
